Strategic alliances between emerging biotechnology companies and established pharmaceutical companies are of critical importance to the life science industry. Our distinguished panelists from biotechnology and pharmaceutical companies will explore the current state-of-the-art in these deals, and why partnering is so vital to both players in the relationship.